Clinical Trial Update: Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury [Phase 4]

View source ↗

Summary

Pfizer's Phase 4 trial evaluating growth hormone treatment for adults with growth hormone deficiency after traumatic brain injury was terminated, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Traumatic Brain Injury

Drugs mentioned

• GENOTROPIN (SOMATROPIN)

Snippet

Sponsor: Pfizer | Conditions: Brain Injuries, Growth Hormone Deficiency | Phase 4 | Status: TERMINATED | Results posted: 2010-06-02